Clinical Trial Detail

NCT ID NCT04454528
Title BreastVax: Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Pennsylvania
Indications

breast cancer

triple-receptor negative breast cancer

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.